Table S1 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients
Fields of Study & Subjects
Ultrasound and Hyperthermia Applications
Intraperitoneal and Appendiceal Malignancies
Hepatocellular Carcinoma Treatment and Prognosis
Publication details
- Publication date
- 4 February 2026